PDS Planning’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $553K | Buy |
1,243
+85
| +7% | +$37.8K | 0.04% | 218 |
|
2025
Q1 | $561K | Buy |
1,158
+334
| +41% | +$162K | 0.05% | 192 |
|
2024
Q4 | $332K | Sell |
824
-18
| -2% | -$7.25K | 0.03% | 269 |
|
2024
Q3 | $392K | Buy |
842
+27
| +3% | +$12.6K | 0.04% | 234 |
|
2024
Q2 | $382K | Sell |
815
-8
| -1% | -$3.75K | 0.04% | 218 |
|
2024
Q1 | $344K | Buy |
823
+46
| +6% | +$19.2K | 0.04% | 225 |
|
2023
Q4 | $316K | Buy |
777
+11
| +1% | +$4.48K | 0.04% | 226 |
|
2023
Q3 | $266K | Buy |
766
+11
| +1% | +$3.83K | 0.03% | 231 |
|
2023
Q2 | $266K | Sell |
755
-175
| -19% | -$61.6K | 0.03% | 239 |
|
2023
Q1 | $293K | Buy |
+930
| New | +$293K | 0.04% | 198 |
|